Results 231 to 240 of about 20,899 (290)

“Applied Medi-Brain Energy-Tronic Treatment Method” for the Medical Treatments of SMA – Spinal Muscular Atrophy Disease, Paralyzed Patients, ALS Patients, MPS, SSPE, DMD Patients with the Biomechanical Analysis of Bionic Prosthetic Robotic Artificial Hand Design

open access: bronze
Assistant Professor Dr, Vocational School of Higher Education for Technical Sciences, Division of Motor Vehicles and Transportation Technologies, Department of Automotive Technology, Iğdır University, Turkey & Graduate School of Natural and Applied Sciences, Major Science Department of Bioengineering and Bio-Sciences, Iğdır University, Turkey
openalex   +2 more sources

Spinal muscular atrophy (SMA) type I (Werdnig-Hoffmann disease)

Archives de Pédiatrie, 2020
Spinal muscular atrophy type I, also called Werdnig-Hoffmann disease, is the most serious form. The disease appears before the age of 6 months and is characterized by major global hypotonia and abolition of tendon reflexes, with children never being able to sit unaided. Cognitive development is normal and the expressive gaze of these children contrasts
F, Audic, C, Barnerias
openaire   +2 more sources

Respiratory management of children with spinal muscular atrophy (SMA)

Archives de Pédiatrie, 2020
Spinal muscular atrophy (SMA) causes a predominantly bilateral proximal muscle weakness and atrophy. The respiratory muscles are also involved with a weakness of the intercostal muscles and a relatively spared diaphragm. This respiratory muscle weakness translates into a cough impairment, resulting in poor clearance of airway secretions and recurrent ...
Fauroux B   +6 more
openaire   +3 more sources

Pathogenesis and therapeutic targets in spinal muscular atrophy (SMA)

Archives de Pédiatrie, 2020
Autosomal-recessive spinal muscular atrophy (SMA) is characterized by the loss of specific motor neurons of the spinal cord and skeletal muscle atrophy. SMA is caused by mutations or deletions of the survival motor neuron 1 (SMN1) gene, and disease severity correlates with the expression levels of the nearly identical copy gene, SMN2.
Lefebvre, S., Sarret, Catherine
openaire   +2 more sources

Home - About - Disclaimer - Privacy